1. Home
  2. BJDX vs HSDT Comparison

BJDX vs HSDT Comparison

Compare BJDX & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BJDX
  • HSDT
  • Stock Information
  • Founded
  • BJDX 2015
  • HSDT 2014
  • Country
  • BJDX United States
  • HSDT United States
  • Employees
  • BJDX N/A
  • HSDT N/A
  • Industry
  • BJDX Medical Specialities
  • HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • BJDX Health Care
  • HSDT Health Care
  • Exchange
  • BJDX Nasdaq
  • HSDT Nasdaq
  • Market Cap
  • BJDX 1.8M
  • HSDT 1.8M
  • IPO Year
  • BJDX 2021
  • HSDT N/A
  • Fundamental
  • Price
  • BJDX $0.07
  • HSDT $0.52
  • Analyst Decision
  • BJDX
  • HSDT Buy
  • Analyst Count
  • BJDX 0
  • HSDT 2
  • Target Price
  • BJDX N/A
  • HSDT $24.00
  • AVG Volume (30 Days)
  • BJDX 48.0M
  • HSDT 116.7K
  • Earning Date
  • BJDX 11-07-2024
  • HSDT 11-12-2024
  • Dividend Yield
  • BJDX N/A
  • HSDT N/A
  • EPS Growth
  • BJDX N/A
  • HSDT N/A
  • EPS
  • BJDX N/A
  • HSDT N/A
  • Revenue
  • BJDX N/A
  • HSDT $502,000.00
  • Revenue This Year
  • BJDX N/A
  • HSDT $16.41
  • Revenue Next Year
  • BJDX N/A
  • HSDT $31.97
  • P/E Ratio
  • BJDX N/A
  • HSDT N/A
  • Revenue Growth
  • BJDX N/A
  • HSDT N/A
  • 52 Week Low
  • BJDX $0.07
  • HSDT $0.37
  • 52 Week High
  • BJDX $31.28
  • HSDT $9.50
  • Technical
  • Relative Strength Index (RSI)
  • BJDX 36.97
  • HSDT 48.71
  • Support Level
  • BJDX $0.08
  • HSDT $0.44
  • Resistance Level
  • BJDX $0.14
  • HSDT $0.58
  • Average True Range (ATR)
  • BJDX 0.03
  • HSDT 0.05
  • MACD
  • BJDX 0.00
  • HSDT 0.01
  • Stochastic Oscillator
  • BJDX 0.54
  • HSDT 42.65

About BJDX Bluejay Diagnostics Inc.

Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.

About HSDT Helius Medical Technologies Inc. (DE)

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

Share on Social Networks: